Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service. Horizon Therapeutics plc HZNP reported first-quarter 2020 adjusted earnings of 40 cents per share, which comprehensively beat the Zacks Consensus Estimate of 23 cents. (b) Agreements, arrangements or understandings relating to options or derivativesįull details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. Dec 12 (Reuters) - Amgen Inc (AMGN.O) on Monday agreed to buy Horizon Therapeutics Plc (HZNP.O) in a deal valued at 27.8 billion, fortifying its rare diseases portfolio in the biggest. About This Report Source: Thomson StreetEvents Company: Horizon Therapeutics PLC Ticker. If there are no such agreements, arrangements or understandings, state none Irrevocable commitments and letters of intent should not be included. Horizon Therapeutics plc HZNP reported fourth-quarter 2021 adjusted earnings of 1.41 per share, which beat the Zacks Consensus Estimate of 1.27. Earnings & Estimates Horizon Therapeutics PLC.
The company reported adjusted earnings of 1.
(a) Indemnity and other dealing arrangementsĭetails of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Horizon Therapeutics PLC balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. NASDAQ: HZNP Market Capitalisation market-capitalisation-info 22,816 Mln 12 Month Earnings monthly-earning 372 Mln Price to Earnings price-to-earning 63.22. Horizon Therapeutics plc HZNP reported first-quarter 2023 adjusted earnings of 83 cents per share, which missed the Zacks Consensus Estimate of 1.17.
0 kommentar(er)
